A detailed history of China Universal Asset Management Co., Ltd. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,579 shares of OVID stock, worth $10,184. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,579
Previous 13,579 -0.0%
Holding current value
$10,184
Previous $41,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$2.72 - $4.04 $14,690 - $21,820
5,401 Added 66.04%
13,579 $41,000
Q4 2023

May 21, 2024

SELL
$2.98 - $3.78 $16,094 - $20,415
-5,401 Reduced 39.77%
8,178 $26,000
Q4 2023

Jan 23, 2024

BUY
$2.98 - $3.78 $24,370 - $30,912
8,178 New
8,178 $26,000
Q3 2022

Oct 21, 2022

BUY
$1.85 - $2.26 $1,221 - $1,491
660 New
660 $1,000

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $52.8M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.